Comparison of Pediatric Septic Shock Treatment With and Without Central Venous Oxygen Saturation Monitoring
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00407823 |
Recruitment Status :
Completed
First Posted : December 5, 2006
Last Update Posted : December 5, 2006
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Severe Sepsis Septic Shock | Procedure: Central venous oxygen saturation continuous monitoring | Not Applicable |
Background: ACCM/PALS guidelines addresses early correction of pediatric septic shock using physical examination supplemented by indirect measures of cardiac output such as central venous or superior vena cava oxygen saturation (ScvO2>70%) in a goal directed approach. However, these endpoints are based on unsupported evidence. The purpose of this study was to compare ACCM/PALS guidelines performed with and without ScvO2 on the morbidity and mortality rate of children with severe sepsis and septic shock.
Methods: Children and adolescents with severe sepsis or fluid-refractory septic shock were recruited at two university-affiliated hospitals and randomly assigned to ACCM/PALS without, or with an ScvO2 goal directed (goal ScvO2 > 70%) resuscitation. Twenty-eight day mortality is the primary end point.
Study Type : | Interventional (Clinical Trial) |
Enrollment : | 268 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Treatment |
Official Title: | An Outcomes Comparison of ACCM/PALS Guidelines For Pediatric Septic Shock With and Without Central Venous Oxygen Saturation Monitoring |
Study Start Date : | January 2004 |
Study Completion Date : | August 2005 |

- 28-day mortality
- Number of organ dysfunction
- Administered treatments
- Duration of cardiovascular agents therapy
- Duration of mechanical ventilation
- Length of Pediatric Intensive Care Unit stay
- Days free of cardiovascular agents
- Days free of mechanical ventilation

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 1 Month to 19 Years (Child, Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- patients with severe sepsis or fluid-refractory septic shock that had not responded after 40 mL/kg of any resuscitation fluid or that required cardiovascular agents at any time during resuscitation
Exclusion Criteria:
- refusal to sign the written informed consent
- age less than 1 month or older than 19 years
- uncorrected cyanotic heart disease
- patients receiving exclusive palliative care
- patients that arrived from other hospitals more than 6 hours after the diagnosis of severe sepsis or septic shock.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00407823
Brazil | |
Instituto da Criança - HC-FMUSP | |
Sao Paulo, SP, Brazil, 05409-002 | |
Hospital Universitário - USP | |
Sao Paulo, SP, Brazil |
Principal Investigator: | Claudio F Oliveira, MD | University of Sao Paulo |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
ClinicalTrials.gov Identifier: | NCT00407823 |
Other Study ID Numbers: |
2004/07949-7 |
First Posted: | December 5, 2006 Key Record Dates |
Last Update Posted: | December 5, 2006 |
Last Verified: | December 2006 |
Child Septic shock Resuscitation |
Central venous oxygen saturation Cardiac output Goal-directed therapy |
Shock, Septic Sepsis Shock Pathologic Processes |
Infections Systemic Inflammatory Response Syndrome Inflammation |